February 12, 2021
CORFU, GREECE – A Greek nurse is now paralyzed after receiving a second dose of mRNA. The 40-year-old nurse is a mother of two and has been a nurse for 17 years. The nurse, whose name has not been disclosed, developed a fever, followed by excruciating pain throughout her body immediately after the second shot. She was rushed to the hospital when she was unable to move or feel her lower extremities.
Michalis Giannakos, President of the Panhellenic Federation of Public Hospital Workers (POEDIN), told Open TV in the East Attica region that X-rays came back clean. The nurse is now undergoing neurological assessments. Giannakos said the nurse “was in perfect health” prior to receiving the second mRNA shot. It is believed that the nurse developed Guillain-Barré syndrome. The neurological disease causes the immune system to attack nerves throughout the body. Giannakos said the nurse is now wheelchair bound.
He defended mRNA shots to an extent. But his human side displayed genuine passion for his injured colleague.
“We do not say anything bad about the vaccine, on the contrary, but the colleague is in a wheelchair and can not get up and has been terrorized,” he said. “I am fully aware of what I am saying. Doctors there also say that it is a side effect of the vaccine.”
It is unclear if she received the Pfizer or Moderna shots. But as of today, Greece has received nearly 800,000 Pfizer doses and 135,000 Moderna doses.
Criminal charges for reporting the truth?
The Prosecution of the Court of First Instance is considering pressing criminal charges against Giannakos. Greek media outlet Ethnos is reporting that a prosecutor is investigating if Giannakos committed the crime of “spreading fake news.” His crime is expressing an mRNA adverse effect with “too much certainty.” We’ll continue following this story for updates.
Contact COVID Legal USA today if you are fighting against mandatory vaccines for employment. We also assist people with pro se representation related to other COVID mandates and restrictions. Follow us on Telegram.